JP2009527510A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009527510A5 JP2009527510A5 JP2008555601A JP2008555601A JP2009527510A5 JP 2009527510 A5 JP2009527510 A5 JP 2009527510A5 JP 2008555601 A JP2008555601 A JP 2008555601A JP 2008555601 A JP2008555601 A JP 2008555601A JP 2009527510 A5 JP2009527510 A5 JP 2009527510A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- binding ability
- peptides
- ability
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- 150000001875 compounds Chemical class 0.000 claims 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 2
- 230000000259 anti-tumor effect Effects 0.000 claims 2
- 229960002897 heparin Drugs 0.000 claims 2
- 229920000669 heparin Polymers 0.000 claims 2
- 230000002163 immunogen Effects 0.000 claims 2
- 101000779583 Limulus polyphemus Anti-lipopolysaccharide factor Proteins 0.000 claims 1
- 206010027476 Metastases Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 150000002270 gangliosides Chemical class 0.000 claims 1
- 230000002519 immonomodulatory effect Effects 0.000 claims 1
- 208000026278 immune system disease Diseases 0.000 claims 1
- 230000015788 innate immune response Effects 0.000 claims 1
- 230000009401 metastasis Effects 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20060047A CU23582A1 (es) | 2006-02-24 | 2006-02-24 | Péptidos con capacidad anti-tumoral e inmunomoduladora |
| CU2006-0047 | 2006-02-24 | ||
| PCT/CU2007/000006 WO2007095867A1 (es) | 2006-02-24 | 2007-02-23 | Peptidos con capacidad anti-tumoral e inmunomoduladora |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009527510A JP2009527510A (ja) | 2009-07-30 |
| JP2009527510A5 true JP2009527510A5 (https=) | 2010-01-28 |
| JP5069250B2 JP5069250B2 (ja) | 2012-11-07 |
Family
ID=38123823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008555601A Expired - Fee Related JP5069250B2 (ja) | 2006-02-24 | 2007-02-23 | 免疫調節及び抗腫瘍ペプチド |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8283324B2 (https=) |
| EP (1) | EP1992638B1 (https=) |
| JP (1) | JP5069250B2 (https=) |
| KR (1) | KR101456205B1 (https=) |
| CN (1) | CN101426813B (https=) |
| AR (1) | AR059608A1 (https=) |
| AT (1) | ATE493434T1 (https=) |
| AU (1) | AU2007218671B2 (https=) |
| BR (1) | BRPI0708148B1 (https=) |
| CA (1) | CA2638828C (https=) |
| CU (1) | CU23582A1 (https=) |
| ES (1) | ES2358845T3 (https=) |
| MX (1) | MX2008010893A (https=) |
| RU (1) | RU2430109C2 (https=) |
| WO (1) | WO2007095867A1 (https=) |
| ZA (1) | ZA200807034B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU23674A1 (es) * | 2007-07-31 | 2011-05-27 | Ct Ingenieria Genetica Biotech | Péptidos penetradores a células fusionados a una biomolécula con acción terapéutica |
| EP2108372A1 (en) * | 2008-04-09 | 2009-10-14 | Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften | Novel antimicrobial peptides |
| EP2476440B1 (en) * | 2009-09-11 | 2017-08-02 | Proyecto de Biomedicina Cima, S.L. | Therapeutic compositions for the treatment of hpv-induced diseases |
| CU23897B1 (es) * | 2010-05-31 | 2013-05-31 | Ct De Ingeniería Genética Y Biotecnología | Péptido para la terapia del cáncer |
| CN103724412A (zh) * | 2013-09-29 | 2014-04-16 | 中国科学院海洋研究所 | 中国明对虾抗脂多糖因子及其制备和应用 |
| CA3260155A1 (en) * | 2022-06-29 | 2024-01-04 | Cdres Pharma Llc | Immunologically active polypeptide |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995005393A2 (en) | 1993-08-18 | 1995-02-23 | Morphosys Gesellschaft Für Proteinoptimierung Mbh | Lipopolysaccharide-binding and neutralizing peptides |
| CU22700A1 (es) * | 1997-09-29 | 2001-07-31 | Ct Ingenieria Genetica Biotech | Formulación farmacéutica anti-viral que contiene un péptido de la proteína factor anti-lps de limulus y su uso |
| US20040101511A1 (en) | 2000-11-08 | 2004-05-27 | Young Aiping H | Combination preparation of a biological response modifier and an anticancer agent and uses thereof |
-
2006
- 2006-02-24 CU CU20060047A patent/CU23582A1/es unknown
-
2007
- 2007-02-22 AR ARP070100749A patent/AR059608A1/es not_active Application Discontinuation
- 2007-02-23 AT AT07711100T patent/ATE493434T1/de not_active IP Right Cessation
- 2007-02-23 EP EP07711100A patent/EP1992638B1/en active Active
- 2007-02-23 MX MX2008010893A patent/MX2008010893A/es active IP Right Grant
- 2007-02-23 CA CA2638828A patent/CA2638828C/en not_active Expired - Fee Related
- 2007-02-23 KR KR1020087023166A patent/KR101456205B1/ko not_active Expired - Fee Related
- 2007-02-23 US US12/278,990 patent/US8283324B2/en not_active Expired - Fee Related
- 2007-02-23 CN CN2007800138842A patent/CN101426813B/zh not_active Expired - Fee Related
- 2007-02-23 AU AU2007218671A patent/AU2007218671B2/en not_active Ceased
- 2007-02-23 ES ES07711100T patent/ES2358845T3/es active Active
- 2007-02-23 BR BRPI0708148A patent/BRPI0708148B1/pt not_active IP Right Cessation
- 2007-02-23 WO PCT/CU2007/000006 patent/WO2007095867A1/es not_active Ceased
- 2007-02-23 JP JP2008555601A patent/JP5069250B2/ja not_active Expired - Fee Related
- 2007-02-23 RU RU2008137968/04A patent/RU2430109C2/ru not_active IP Right Cessation
-
2008
- 2008-08-14 ZA ZA200807034A patent/ZA200807034B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230073594A1 (en) | Lactoferrin compositions and methods for modulation of t cell subtypes and treatment of autoimmune diseases | |
| EP2594582A3 (en) | Peptide vaccines with Seq Id No: 110, 111, 387, 112, 394 114, 116, 117 or 121 for cancers expressing tumor-associated antigens | |
| JP2009527510A5 (https=) | ||
| WO2008118017A3 (en) | Prame derived peptides and immunogenic compositions comprising these | |
| JP2015501656A5 (https=) | ||
| ATE447585T1 (de) | Antigener komplex, der ein immunstimulierendes peptid enthält, cd4 und chemokinrezeptor-domäne zur behandlung von hiv und immunerkrankungen | |
| HRP20180216T1 (hr) | Fuzijski proteini i kombinacijska cjepiva koja sadrže protein e i pilin a iz bakterije haemophilus influenzae | |
| UA107571C2 (xx) | Фармацевтична композиція | |
| NZ604818A (en) | Variants of activin iib receptor polypeptides and uses thereof | |
| JP2006506942A5 (https=) | ||
| JP2015514132A5 (https=) | ||
| KR20120046163A (ko) | 자가면역, 염증 및 암의 과정을 저해할 수 있는 신규한 케모카인 결합 폴리펩타이드류 | |
| JP2013501007A5 (https=) | ||
| UA100127C2 (ru) | Пептид cdh3 и лекарственное средство, содержащее его | |
| JP2012102105A5 (https=) | ||
| RU2013126888A (ru) | ИММУНОМОДУЛИРУЮЩИЕ КОМПОЗИЦИИ, СПОСОБЫ И СИСТЕМЫ, СОДЕРЖАЩИЕ ИММУНОГЕННЫЕ ФРАГМЕНТЫ АроВ100 | |
| WO2010007144A3 (en) | Mutated netrin-4 proteins, fragments thereof and their uses as drugs | |
| RU2008137968A (ru) | Иммуномодулирующие и противоопухолевые пептиды | |
| EP2481748A3 (en) | Foxp3 peptide vaccine | |
| WO2007125210A3 (fr) | Utilisation de ligands synthetiques multivalents de la nucleoline de surface pour le traitement du cancer ou de l'inflammation | |
| WO2010103515A3 (en) | Compositions and methods for prevention and treatment of neurodegenerative diseases | |
| WO2008047370A3 (en) | Compositions and methods for inducing angiogenesis | |
| WO2007142582A8 (en) | Fluorescent proteins and genes encoding them | |
| JP2011528665A5 (https=) | ||
| JP2009544304A5 (https=) |